Allena Pharmaceuticals, Inc. 10,400,000 Shares of Common Stock (par value $0.001 per share) Amended and Restated Underwriting AgreementUnderwriting Agreement • December 3rd, 2020 • Allena Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Allena Pharmaceuticals, Inc., a company incorporated under the laws of the State of Delaware (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 10,400,000 shares of its common stock, par value $0.001 per share (the “Shares”). The 10,400,000 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 1,560,000 Shares as provided in Section 2. The additional 1,560,000 Shares that may be sold by the Company pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, the Optional Shares, are collectively called the “Offered Shares.” H.C. Wainwright & Co., LLC (“Wainwright”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Sha
